Skip to main content
. 2023 Oct 6;13:16839. doi: 10.1038/s41598-023-44174-8

Figure 2.

Figure 2

MALAT1 expression is an independent prognostic factor for time to treatment (TTT) in CLL. (a) CLL patients with high MALAT1 expression showed significantly shorter TTT compared to those with low levels in the global cohort (top panel) and almost every one of the different CLL subgroups related to the IGHV mutational status (bottom left) and epigenetic subtypes (bottom right). (b) Plot for multivariate model analyses, where MALAT1 expression as a continuous variable shows its independent prognostic value considered together with Binet stage and IGHV mutational status (left panel) or epigenetic subtypes (right panel). For epigenetic groups, m-CLL was taken as a reference.